Fs-laser safe for capsulotomy creation

Article

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Researchers from Moorfields Eye Hospital, London, conducted a prospective consecutive case series that evaluated 1,000 femtosecond laser–assisted cataract cases performed at the hospital between January 2013 and March 2014. During that time, platform software versions 2.15, 2.15.13, and 2.20 of the femtosecond laser system were used. The researchers evaluated the rate of complete capsulotomies that were performed without adhesions and anterior capsule tears.

The researchers found that in 998 of the 1,000 cases (99.8%), a complete 360-degree capsulotomy was present without adhesions or bridging tags. There were no cases of intraoperative tears of the anterior capsule.

There were 2 cases of incomplete capsulotomy: 1 in which the laser was aborted during the procedure and the procedure was completed manually, and 1 in which a single bridging tag adhesion occurred at capsulotomy removal, and a radial tear was identified after removal of the nucleus. The tear did not extend to the posterior capsule.

To read the abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.